8-K current report · filed Nov 10, 2026

CARLSMED, INC. (CARL) 8-K Current Report: November 10, 2026

Item 2.02Item EX-99.1CARL overview

Short answer

CARLSMED, INC. (CARL) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for quarter ended September 30, 2026.

CARLSMED, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results announced for quarter ended September 30, 2026
  • Full results and investor-relevant metrics available in Exhibit 99.1 press release

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $21.6M, up 65% year over year, signaling strong adoption of Carlsmed’s AI-enabled spine platform
  • Full-year revenue guidance raised to $78M-$80M from $74M-$78M, implying over 56% midpoint growth
  • Gross margin improved to 77.3% from 75.9%, supporting the company’s capital-light profitability strategy
  • GAAP net loss widened to $12.2M from $8.5M as operating expenses reached $29.4M, including $2.8M of transition and legal costs
  • Cash, investments and securities totaled $80.3M, while adjusted EBITDA improved to negative $7.3M from negative $8.2M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CARLSMED, INC. 8-K filings

Get the next CARL 8-K as it lands

Follow CARL for push alerts, or ask the research agent what this filing means.